EcoDrugPlus

Natriuretic Peptide Receptor 3

Ensembl ID : ENSAPEG00000024339
Gene Symbol: NPR3
1 Cross references
210 Possible Orthologues:

Neuropeptide Y Receptor Y2

Ensembl ID : ENSAPEG00000017901
Gene Symbol: NPY2R
1 Cross references
175 Possible Orthologues:

Neuropeptide Y Receptor Y2

Ensembl ID : ENSAPEG00000002151
Gene Symbol: NPY2R
1 Cross references
183 Possible Orthologues:

Neuropeptide Y Receptor Y2, Like

Ensembl ID : ENSAPEG00000017800
Gene Symbol: NPY2RL
1 Cross references
175 Possible Orthologues:

Neurotensin Receptor 1

Ensembl ID : ENSAPEG00000003020
Gene Symbol: NTSR1
1 Cross references
162 Possible Orthologues:

Neurotensin Receptor 1

Ensembl ID : ENSAPEG00000003055
Gene Symbol: NTSR1
2 Cross references
193 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 2

Ensembl ID : ENSAPEG00000003079
Gene Symbol: NTRK2
1 Cross references
209 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 3

Ensembl ID : ENSAPEG00000006663
Gene Symbol: NTRK3
1 Cross references
203 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 3

Ensembl ID : ENSAPEG00000018302
Gene Symbol: NTRK3
1 Cross references
183 Possible Orthologues:

Neurotrophic Tyrosine Kinase, Receptor, Type 1

Ensembl ID : ENSAPEG00000022877
Gene Symbol: NTRK1
1 Cross references
200 Possible Orthologues:

Neurotrophic Tyrosine Kinase, Receptor, Type 2b

Ensembl ID : ENSAPEG00000019720
Gene Symbol: NTRK2B
1 Cross references
210 Possible Orthologues:

Nfe2 Like Bzip Transcription Factor 2a

Ensembl ID : ENSAPEG00000022542
Gene Symbol: NFE2L2A
1 Cross references
205 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).